
The Supreme Court is considering a lawsuit meant to reverse the Food and Drug Administration’s approval of the abortion pill mifepristone. The case has major ramifications for abortion access, given that a majority of abortions are now performed via medication. It also could reshape the 2024 elections, in which abortion is expected to be a significant consideration for voters. The Washington Examiner is featuring a series of articles providing an in-depth look at the case and its implications. Th …